Sylogist: Fundamental Tailwinds In Place
Sylogist's new logo growth and cross-selling strategies make it an attractive investment with strong IRR potential despite ...
SelectQuote: Better Prospects After Bain Deal, But Don't Rush To Buy (Upgrade)
SelectQuote shares surged ~30% on strong Q2 results and a $350M Bain Capital-led investment. Revenue grew 19%. Click to see ...